Our thought leadership in action
Missed us at ISPOR 2025? Connect with our experts to learn more
Educational symposia
Bringing us together or pushing us apart: Will JCA, HEMA, and other cross-border collaboration initiatives improve patient access?
Panelists: Jon Campbell, National Pharmaceutical Council; Michael Drummond, University of York; Eldon Spackman, University of Calgary
With team across North America, Europe, and Japan, we blend global reach with local expertise
Innomar Strategies
Ensuring commercialization success in Canada
Explore our poster presentations at ISPOR 2025
- An evaluation of PhlexNeuron, an internal, proprietary artificial intelligence (AI) tool for systematic literature review (SLR) screening
- Analysis of the effect of Trofinetide treatment on the domain and item-level responses of the Rett syndrome behavior questionnaire using data from the LAVENDER trial
- Broadening the scope of value: Evaluating payer perspectives and insights on ICER’s latest initiatives and tools
Cost-effectiveness analyses of Repotrectinib in TKI-naïve patients with ROS1+ advanced non-small cell lung cancer
- Developing a Large Language Model-Based Simulation for P&T Committees: Methodology and Inputs for Realistic Dynamics
- Inclusion of health-related quality of life (HRQoL) and other patient-reported outcomes (PROs) in the United States Food and Drug Administration (FDA) labels
- Leveraging artificial intelligence to streamline study quality assessment in systematic literature reviews
Payer perceptions on creating a national value assessment body in the US
- Payer perspectives on ICER Evidence Reports: Insights into utility for coverage and formulary decision-making
- Staffing resource use: a cost impact model for the utilization and implementation of medications for opioid use disorder within US jails and prisons
Cencora partners with ISPOR to advance HEOR
Catch up on our latest insights
Catch up on the latest edition of HTA Quarterly
Navigating the Canadian reimbursement landscape
Connect with our team
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.